Key result
Resident and monocyte-derived cardiac macrophages link immunometabolism to HFpEF pathogenesis and offer subset-specific therapeutic targets.
Why the study?
Targeting specific macrophage subsets offers promising therapeutic avenues in HFpEF, but challenges like off-target effects and clinical translation remain.
This review elucidates the immunometabolic crosstalk and distinct roles of macrophage subsets in HFpEF, highlighting emerging subset-specific therapeutic strategies.
Answers are grounded in this paper and cite their sources.
Immunometabolic targeting of macrophage subsets merits exploration in HFpEF; hypothesis-generating and requires prospective trials before clinical adoption.
Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome driven by comorbidities, chronic low-grade inflammation, and cardiac remodeling. Cardiac resident macrophages (CRMs) and monocyte-derived macrophages (MDMs) play central roles in linking immunometabolism to HFpEF pathogenesis. Resident CCR2 - macrophages maintain homeostasis and tissue repair, whereas monocyte-derived CCR2 + macrophages drive inflammation, fibrosis, and diastolic dysfunction. In HFpEF, comorbidity-induced metabolic shifts promote pro-inflammatory macrophage polarization, while metabolites like fatty acids, lactate, and succinate modulate these responses through metabolic and epigenetic pathways. Targeting specific macrophage subsets offers promising therapeutic avenues, though challenges like off-target effects and clinical translation remain. This review summarizes cardiac macrophage heterogeneity, immunometabolic crosstalk, and regulatory mechanisms in HFpEF, highlighting emerging subset-specific therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) conducted a review in Heart failure with preserved ejection fraction (HFpEF). Cardiac resident macrophages and monocyte-derived macrophages play central roles in linking immunometabolism to HFpEF pathogenesis, offering promising subset-specific therapeutic avenues.
Synapse has enriched 10 related papers. Consider them for comparative context: